期刊文献+

多发性内分泌腺瘤2A型一家系中的原癌基因RET p.C618R突变 被引量:2

Multiple endocrine neoplasia type 2A caused by a p. C618R RET proto-oncogene mutation in a Chinese pedigree
原文传递
导出
摘要 目的探讨多发性内分泌腺瘤2A型(multiple endocrine neoplasia type2A,MEN2A)的临床特点及RET原癌基因检测的意义。方法对1个MEN2A家系进行系统的临床家系调查和种系水平的RET基因检测。结果基因检测该家系5位成员中3例存在RET基因p.C618R杂合错义突变,与临床完全相符。男1例,女2例。首次诊断年龄分别为21岁、26岁和36岁。甲状腺髓样癌最大直径分别为2.2cm、2.5cm和3.9cm。36岁女患者首次手术仅接受了右侧甲状腺全切+右颈部淋巴结清扫术,4年后先、后接受了左侧肾上腺嗜铬细胞瘤切除术、左侧甲状腺全切+左侧颈部淋巴结清扫术;21岁男患者接受了右侧甲状腺全切+右侧颈部改良淋巴结清扫术。2例患者分别随访146、26个月,降钙素仍均升高伴双侧颈部淋巴结肿大或伴左侧甲状腺占位。26岁女患者伴双侧甲状腺占位和降钙素升高,但拒绝治疗。结论结合临床筛查和RET基因检测,有利于MEN2A的及早诊断和规范化治疗,提高远期治愈率。 Objective To explore the clinical characteristics and significance of RET proto-oncogene screening in multiple endocrine neoplasia type 2A(MEN2A). Methods Comprehensive medical history was obtained for 5 members from a 3-generation family from southern China. Clinical investigations have included biochemical testing, imaging, and screening of germline RET proto-oncogene mutations. Results Genetic screening has revealed a missense mutation at codon 618(TGC〉CGC) of exon 10 in 3 patients(p. C618R), which was consistent with their clinical manifestations. For the3 individuals, the age at diagnosis was 21, 26 and 36, and the maximum diameter of medullary thyroid cai'cinoma was 2.2, 2.5 and 3.9 cm, respectively. The 36-year-old female patient initially underwent right total thyroidectomy plus right neck lymph node dissection. Four years later, she again underwent left adrenal tumorectomy and left total thyroidectomy plus left neck lymph node dissection. The 21-year-old male patient underwent right total thyroidectomy plus right modified neck dissection. The follow-up was respectively 146 and 26 months following the initial operation. Two patients still presented elevated calcitonin and had bilateral neck lymph node masses and/or left thyroid masses on imaging examination. The 26-year-old female patient, who presented bilateral thyroid masses and elevated calcitonin, has refused thyroidectomy. Conclusion Combined family survey and RET gene screening can facilitate early diagnosis and surgical treatment to improve the prognosis.
出处 《中华医学遗传学杂志》 CAS CSCD 北大核心 2014年第3期348-351,共4页 Chinese Journal of Medical Genetics
基金 南京军区医学科技创新课题基金重点项目(092038,102036)
关键词 多发性内分泌腺瘤2型 甲状腺髓样癌 肾上腺嗜铬细胞瘤 RET原癌基因 点突变 Multiple endocrine neoplasia type 2A Medullary thyroid carcinoma Pheochromocytoma RET proto-oncogene Point mutation
  • 相关文献

参考文献14

  • 1Kloos RT, Eng C, Evans DB, et al. Medullary thyroid cancer: management guidelines of the American Thyroid Association[J]. Thyroid, 2009,19 : 565-612. 被引量:1
  • 2Qi XP, Chen XL, Ma JM, et al. RET proto-oncogene genetic screening of families with multiple endocrine neoplasia type 2 optimizes diagnostic and clinical management in China [J ]. Thyroid, 2012,22: 1257-1265. 被引量:1
  • 3Qi XP, Ma JM, Du ZF, et al. RET germline mutations identified by exome sequencing in a Chinese multiple endocrine neoplasia type 2A/Familial medullary thyroid carcinoma Family [J]. PLoSOne, 2011, 6:e20353(1-9). 被引量:1
  • 4Qi XP, Ying RB, Ma JM, et al. Case report:A p. C618S RET proto-oncogene germline mutation in a large Chinese pedigree with familial medullary thyroid carcinoma[J]. Familial Cancer, 2012,11 : 131-136. 被引量:1
  • 5赵坚强,郭良,戚晓平,陈振光,王可敬,楼建林,余秀华,成军,金杭阳,李小龙,应荣彪,张成宁.RET原癌基因p.C618Y突变的家族性甲状腺髓样癌一家系的临床诊治分析[J].中华医学杂志,2013,93(6):440-444. 被引量:13
  • 6Frank-Raue K, Rybicki LA, Erlic Z, et al. Risk profiles and penetrance estimations in multiple endocrine neoplasia type 2A caused by germline RET mutations located in exon 10[J]. Hum Murat,2011,32: 51-58. 被引量:1
  • 7韩战营,邱春光,陈庆华,祝宇,朱鼎良.散发性嗜铬细胞瘤患者RET原癌基因突变检测[J].中华医学遗传学杂志,2006,23(3):320-322. 被引量:4
  • 8Yao B, Liu X, Liang H,et al. A novel mutation(D631 del) of the RET gene was associated with MEN2A in a Chinese pedigree [J]. Endoer J,2009,56:99-104. 被引量:1
  • 9Pasini B, Rossi R, Ambrosio MR, et al. RET mutation profile and variable clinical manifestations in a family with multiple endocrine neoplasia type 2A and Hirschsprung' s disease [J]. Surgery, 2002,131 : 373-381. 被引量:1
  • 10Neocleous V, Passalaris T, Spanou E, et al. Description of the first two seemingly unrelated Greek cypriot families with a common C618R RET proto-oncogene mutation[J]. Genet Test, 2004,8:163-168. 被引量:1

二级参考文献35

  • 1曾正陪.多内分泌腺瘤病.史轶繁主编.协和内分泌和代谢学.第1版.北京:科学技术出版社,1999,1607-1621. 被引量:1
  • 2Januszewicz A,Neumann HP,Lon I,et al.Incidence and clinical relevance of RET proto-oncogene germLine mutations in pheochromocytoma patients.J Hypertens,2000,18:1019-1023. 被引量:1
  • 3Eng C.RET proto-oncogene in the development of human cancer.J Clin Oncol,1999,17:380-393. 被引量:1
  • 4Hamet P,Pausova Z,Adarichev V,et al.Hypertension:genes and environment.J Hypertens,1998,16:397-418. 被引量:1
  • 5Mulligan LM,Marsh DJ,Robinson BG,et al.Genotype-phenotype correlation in multiple endocrine neoplasia type 2:report of the International RET Mutation Consortium.J Intern Med,1995,238:343-346. 被引量:1
  • 6Marsh DJ,Robinson BG,Andrew S,et al.A rapid screening method for the detection of mutations in the RET proto-oncogene in multiple endocrine neoplasia type 2A and familial medullary thyroid carcinoma families.Genomics,1994,23:477-479. 被引量:1
  • 7Mulligan LM,Kwok JB,Healey CS,et al.Germ-line mutations of the RET proto-oncogene in multiple endocrine neoplasia type 2A.Nature,1993,363:458-460. 被引量:1
  • 8Michiels FM,Chappuis S,Caillou B,et al.Development of medullary thyroid carcinoma in transgenic mice expressing the RET proto-oncogene altered by a multiple endocrine neoplasia type 2A mutation.Proc Natl Acad Sci U S A,1997,94:3330-3335. 被引量:1
  • 9American Thyroid Association Guidelines Task Force. Medullary thyroid cancer: management guidelines of the American Thyroid Association. Thyroid, 2009, 19: 565-612. 被引量:1
  • 10Qi xP, Ying RB, Ma JM, et al. Case report: a p. C618S RET proto-oncogene germline mutation in a large Chinese pedigree with familial medullary thyroid carcinoma. Fam Cancer, 2012, 11: 131-136. 被引量:1

共引文献22

同被引文献16

引证文献2

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部